Risk factors for breast cancer-related lymphedema in patients undergoing 3 years of prospective surveillance with intervention.

Louise A KoelmeyerKatrina GaitatzisMary S DietrichChirag A ShahJohn BoyagesSarah A McLaughlinBret TabackDeonni P StolldorfElisabeth ElderT Michael HughesJames R FrenchNicholas NguiJeremy M HsuAndrew MooreSheila H Ridner

Published in: Cancer (2022)

Within the context of 3 years of PSEI for subclinical lymphedema, variables of ALND, taxane-based chemotherapy, RNI, body mass index >30, and rurality increased risk.

Keyphrases

patients undergoing
randomized controlled trial
public health
locally advanced
squamous cell carcinoma
drug induced
chemotherapy induced